Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-09-006003
Filing Date
2009-11-25
Accepted
2009-11-25 16:27:52
Documents
1
Period of Report
2009-11-23

Document Format Files

Seq Description Document Type Size
1 c59511_ex.html 4  
1 c59511_ex.xml 4 5282
  Complete submission text file 0000930413-09-006003.txt   7445
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARMACEUTICALS INC. RTE 202/206 BRIDGEWATER NJ 08807
Business Address
del Campo Ralph (Reporting) CIK: 0001323683 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 091208672